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Abstract
With the emerging interest in documenting and understanding
muscle atrophy and function in critically ill patients and survivors,
ultrasonography has transformational potential for measurement of
muscle quantity and quality. We discuss the importance of quantifying
skeletalmuscle in the intensivecareunit setting.Wealso identify themerits
and limitations of various modalities that are capable of accurately and
precisely measuring muscularity. Ultrasound is emerging as a potentially
powerful tool for skeletal muscle quantiﬁcation; however, there are key
challenges that need to be addressed in future work to ensure useful
interpretation and comparability of results across diverse observational
and interventional studies. Ultrasound presents several methodological
challenges, and ultimately muscle quantiﬁcation combined with
metabolic, nutritional, and functional markers will allow optimal patient
assessment and prognosis. Moving forward, we recommend that
publications include greater detail on landmarking, repeated measures,
identiﬁcation of muscle that was not assessable, and reproducible
protocols to more effectively compare results across different studies.
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The ﬁeld of acute muscle wasting in
critical illness has expanded signiﬁcantly
with an understanding and characterization
of functional impairment in survivors of
critical illness. Muscle wasting is one of
the greatest problems that survivors
exhibit, which contributes to muscle
weakness. Both quality-of-life
questionnaires and functional walking
tests have demonstrated muscle weakness
as a primary contributor to functional
disability (1–10). However, the underlying
mechanisms of muscle weakness in the
intensive care unit (ICU) survivors are
poorly understood.
Muscle weakness is driven by loss of
muscle mass, metabolic and physiological
dysregulation of skeletal muscle,
degradation in skeletal muscle architecture,
and dysfunctional central and peripheral
neural signals. Because these elements
represent a composite of muscle health, it is
important to evaluate them as a whole
rather than independently. Many of these
variables often require volitional
assessment, which in many cases can be
invasive and expensive. Obtaining objective
and feasible measures of muscle health at
admission and during the trajectory of
critical illness is challenging, given the
unstable and weakened condition of
patients; therefore, nonvolitional methods
and surrogate measures are needed to
assess muscle health (11). Previous reports
highlight that up to 60% of critically ill
patients fail common screening processes
for manual muscle testing at awakening
(11, 12) and that approximately 12% are
unable to complete the test, owing to death,
pain, or refusal (12). There is also a
time-critical period following ICU
admission that occurs prior to awakening
(on average, 7–12 d) when patient
participation in assessments is not possible
but during which accelerated rates of
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muscle wasting are known to occur
(13–15).
Features of skeletal muscle (including
muscle quantity measures such as mass
and cross-sectional area and muscle quality
measures such as architecture and evidence
of myonecrosis) may provide amore feasible
and objective approach to assessing muscle
health in ICU patients. With the ultimate
focus on physical activity and functional
outcomes, it is not surprising that the
quadriceps muscles, which are an important
weight-bearing muscle group, have been
the most extensively studied region of the
body. Lower limb muscle mass and strength
have repeatedly been shown to correlate
in diverse populations, including in ICU
survivors (13, 16–18). Although muscle
mass may technically be a surrogate
measure of muscle function, not all studies
support this relationship (19, 20). Objective
quantiﬁcations of muscle (which include
but are not limited to muscle mass,
thickness, and cross-sectional area) that are
sufﬁciently sensitive to detect small changes
over acute time frames may ultimately
facilitate evaluation of interventions to
counter muscle atrophy and weakness.
Over the last decade, common
imaging technologies such as ultrasound
(13, 21–23) and computed tomography
(CT) (23–27) have been translated to the
ICU for quantiﬁcation of muscle. The
transformational application of these
techniques has advanced understanding
of the muscle characteristics of ICU
patients at admission and during the ICU
trajectory. Quantiﬁcation of skeletal muscle
(13), an example of this transformational
application, allows for identiﬁcation of
those with low muscle quantity (21). Low
muscle quantity in turn has been related to
poor clinical outcomes, including increased
mortality as well as reduced ventilator-free
days and ICU-free days (25–27).
Approximately 63% of ICU patients
have low muscle cross-sectional area as
measured by CT at the time of ICU
admission (25), and this prevalence
increases to approximately 70% when ICU
patients are aged 65 years or older (26).
Ultrasonography has also demonstrated
approximately 8 to 30% loss of muscle
within the ﬁrst 7–10 days of ICU
admission (13, 14), and muscle atrophy
has been associated with degree of organ
failure as well as increased ICU length of
stay (14, 28, 29). Muscle weakness may
independently predict clinical outcomes,
including mortality (30, 31), ventilator-
dependent time (15, 30, 32), and hospital
length of stay (30). Muscle atrophy and
weakness are likely related to catabolic
processes such as inﬂammation during
and following critical illness (33) as well as
immobility or lack of activity (Figure 1)
(34, 35). The fact that muscle wasting and
muscle weakness occur is not new to
clinicians; Asher alluded to this
phenomenon in his treatise on bed rest in
1947 and placed “beds and graves in the
same category” (36, p. 967).
Need for Precise and Accurate
Modalities for Muscle
Quantiﬁcation
Precise and accurate muscle quantiﬁcation
at a single time point and for longitudinal
analysis is valuable for (1) characterizing
metabolic and functional changes in lean
tissue, (2) understanding the underlying
mechanisms of muscle wasting, and (3)
assessing the success or failure of
therapeutic interventions. Adverse
metabolic adaptations secondary to muscle
atrophy may also contribute to these poor
functional and clinical outcomes, but the
measurement of muscle metabolism is
elusive in critically ill patients and
survivors.
Skeletal muscle is fundamental to
immune and cytokine function (37) and
accounts for greater than 75% of glucose
disposal (38). Thus, ICU-associated muscle
atrophy and deleterious changes in muscle
integrity are expected to complicate glucose
regulation and various processes affected by
inﬂammation. Maintaining and restoring
skeletal muscle becomes challenging, given
that patients exhibit a vicious cycle of
attenuated protein synthesis and
accelerated protein breakdown. This vicious
cycle is driven by ICU-related bed rest (33),
reduced caloric and protein intake (39, 40),
a proinﬂammatory state (41, 42), and
anabolic and insulin resistance (deﬁned as
the reduced ability to take up amino acids
and glucose into muscle, respectively) (43,
44) (Figure 1). Body composition measures,
speciﬁcally ultrasonography, present the
potential opportunity to noninvasively
characterize muscle health by measuring
change in muscle quantity (e.g., muscle
mass) and muscle quality (e.g.,
development of myonecrosis, fatty
inﬁltration) (Figure 2).
Measuring Up: Methods for
Muscle Quantiﬁcation
Body mass index (BMI), bioelectrical
impedance analysis (BIA), dual-energy
X-ray absorptiometry (DXA), CT, magnetic
resonance imaging (MRI), and
ultrasonography are currently available as
tools for assessing muscle mass. Research
focused on understanding muscle atrophy
has been impeded by the lack of available
tools for measuring muscle mass that (1) are
easily deployable within the constraints of
an ICU, (2) have low/no risk to patients,
and (3) are able to accurately track both
muscle atrophy and recovery. Body
composition, often coupled with additional
metabolic/biochemical biomarkers, is
increasingly used to quantify changes in
muscle mass and integrity. Next, we brieﬂy
discuss the merits and challenges of these
modalities, which are more elaborately
reviewed elsewhere (23, 45).
Historically, weight, BMI, or BIA has
been used in various nutrition studies to
describe changes in body composition
and evaluate intervention efﬁcacy.
Pronounced edema and ﬂuid shifts in
patients, combined with the lack of
speciﬁcity and variability in these measures,
impede the usefulness of these tools in
understanding speciﬁc muscle changes in
ICU patients and recovery in survivors.
Importantly, weight and BMI are general
measures of body size and cannot
distinguish between fat and lean tissue.
Weight lost during hospitalization may be
regained within 1 year of ICU discharge, but
as fat mass rather than lean mass (46, 47).
Such changes in weight can increase risk of
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Figure 1. Depiction of diverse factors that
contribute to the progressive cycle of reduced
protein synthesis and increased protein breakdown
leading to muscle atrophy in critically ill patients.
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morbidity and reduce quality of life,
demonstrating the importance of accurate
tracking of muscle and fat mass. Studies
that examine muscle atrophy and weakness
in ICU survivorship therefore need to
include speciﬁc and accurate quantiﬁcation
of muscle.
BIA is commonly used to determine
total body water, which is then used to
estimate fat-free mass using body weight
(48). Given its reliance on the conductive
properties of water for estimating lean
tissue mass, BIA is susceptible to
inaccuracies secondary to large ﬂuxes in
ﬂuid status that present in critically ill
patients (49–51). This, coupled with the
lack of reliable weight measures in critical
care, lack of predictive equations for this
cohort, and limitations in the positioning of
the patient for accurate measures, reduces
the usefulness of this modality. However,
emerging work suggests that BIA may
provide information on ﬂuid shifts (by
calculating impedance ratio) as well as cell
membrane integrity and body cell mass
(based on phase angle calculations). When
these measures are combined with
commonly collected covariates, they may
predict muscularity in this population (52).
DXA is performed with a scanner that
uses two X-ray beams of different energy
levels to distinguish lean and fat tissue. It
is a powerful modality for accurately and
precisely measuring lean tissue with little
radiation exposure. It permits the
compartmentalization of speciﬁc regional
lean tissue measures where there may be
interest in understanding whether muscle
atrophy is universal or regional in ICU
patients as well as evaluating potential
regional improvements following targeted
rehabilitation. Its use has been limited in the
ICU, given the sparse accessibility of the
equipment and the logistics of patient transfer.
In only a single study to date, researchers
evaluated lean tissue mass in 49 ICU patients
using DXA (50); however, the data were
used to validate BIA methods and thus
have little relevance to muscle atrophy.
CT andMRI offer precise, accurate, and
reliable measures of muscle cross-sectional
area and volume as well as muscle integrity
(quality), but their use is limited in the critical
care setting. Most studies are based on
retrospective analysis of computed
tomographic images of the third lumbar
vertebral (L3) region. Although studies in
healthy (53) and cancer populations (54)
suggest that the L3 region is representative
of whole-body skeletal muscle or lean tissue
distribution, it is unknown whether muscle
atrophy occurs globally or in speciﬁc regions
of the body. Although De Jonghe and
colleagues (32) showed that respiratory and
limb weakness are associated, the magnitude
and etiology of muscle atrophy in proximal
versus distal muscle groups may be distinct.
Future work is needed to investigate whether
muscle atrophy occurs in multiple locations
and to elucidate the underlying mechanisms
that drive these losses.
In addition, the retrospective nature of
most studies using CT or MRI prohibits the
proper design of longitudinal studies.
Selection bias is also introduced by
restricting the study population to those
patients who require abdominal CT or
MRI for diagnostic purposes. Prospective
computed tomographic or MRI analysis is
associated with patient transport outside
the ICU (and its accompanying risks), cost,
and safety concerns (e.g., CT radiation
dose), all of which preclude their use in
research studies and, for now, clinical
evaluation of muscle mass and quality.
Researchers in one study used prospective
computed tomographic imaging (24), but
the study’s limited sample size (n = 8)
precludes extrapolation. Despite these
limitations, knowledge of muscle atrophy in
critically ill patients has been signiﬁcantly
advanced by these modalities (21, 25, 26).
B-mode ultrasound has emerged as
an attractive method, being easily accessed
by researchers as a result of its central
and expanding role in a variety of clinical
bedside procedures. Skeletal muscle
ultrasound is not a new technique; reports
of its use in the ICU setting date back
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Figure 2. Several quantitative and qualitative features of skeletal muscle can be measured using ultrasound that are associated with clinical and functional
outcomes. ICU = intensive care unit.
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2 decades, and it has been used in pediatric
muscle disease for more than 30 years. More
recent work employing this technique has
been focused on understanding muscle loss
in aging (55, 56) and chronic disease
populations (17, 57). Two imaging aspects are
of interest: muscle quantiﬁcation (e.g., muscle
layer thickness or cross-sectional area of an
individual muscle or muscle group; Figure 3)
and muscle quality (echogenicity). On one
hand, in healthy volunteers and ambulant
disease states (e.g., chronic obstructive
pulmonary disease, chronic heart or renal
failure), measures of muscle cross-sectional
area correlate with strength (57), and this
assessment may have a conceivable use in
guiding rehabilitation. Echogenicity, on the
other hand, offers the opportunity to
potentially evaluate the integrity of muscle
(i.e., muscle biomechanics, fatty inﬁltration,
presence of myonecrosis; Figure 2) (58, 59).
Current State of the
Translational Use of Critical
Care Muscle Ultrasound
In the past 5 years (2011–2016), 11
observational studies (13, 14, 19, 28, 59–65)
and 3 interventional studies (66–68) using
ultrasound measures of skeletal muscle as an
outcome in critically ill patients have been
published. Currently, an additional 13 trials
using ultrasound measures as outcomes are
registered with www.clinicaltrials.gov,
suggesting that ultrasonography is being
rapidly adopted by clinicians in multiple
disciplines for measuring muscle features.
However, the technique of critical care
skeletal muscle ultrasound lags behind other
critical illness research domains where
standardization of deﬁnitions (60), gradation
of severity (60, 61), and technical skills (62)
have allowed assessment of external validity
of data produced.
Challenges in Critical Care
Muscle Ultrasound Studies
Although ultrasonography is an attractive
tool for evaluating muscle health, several
uncertainties and limitations need to be
considered (summarized in Table 1). The
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Figure 3. Illustrations of diverse patient and scan characteristics obtained by ultrasonography. (A) Anatomical labels are identified in a scan depicting
muscle layer thickness of a 23-year old non–intensive care unit female with a body mass index of 22.8 kg/m2. Muscle layer thickness would include rectus
femoris and vastus intermedius depicted in red. (B) Example of cross-sectional area of a rectus femoris muscle highlighted in red. (C ) Muscle layer
thickness is shown for a non–intensive care unit individual who has a body mass index of 28.9 kg/m2 and body fat percentage of 45.6% (measured using
dual-energy X-ray absorptiometry). The red line depicts muscle layer thickness. (D) Muscle layer thickness is imaged using a linear probe and depicted in
red. (E ) Muscle layer thickness is imaged using a curvilinear probe, depicted in red, in the same individual as in (D). B = bone; INT = interface between
subcutaneous adipose tissue and rectus femoris; RF = rectus femoris; S = skin; SAT = subcutaneous adipose tissue; VI = vastus intermedius.
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discussion below offers an overview and is
intended to highlight areas to be addressed
in future work. This brief discussion is
critically important, given the rapid
expansion in the adoption of ultrasound
imaging in clinical and research practice as
well as the lack of standardization in the
approaches used.
Training
Although muscle ultrasound is relatively
straightforward to perform, appropriate
training is required (63). Currently, there is
no formal training program or standardized
protocol used to educate clinicians, health
care providers, or students. Importantly,
reliability, reproducibility, and accuracy
should not be assumed; thus, data
pertaining to these aspects should be
made available in studies, and general
reporting standards should be developed.
Within this context, standardized
protocols are needed in terms of the
following (additional details can be found
in Table 2):
d Blinding for reliability tests
d Number of repeated measures needed
d Reliability tests for landmarking
d Reliability tests for measuring thickness
or cross-sectional area
d Inclusion of intra- and interreliability
measures
d Consideration of patient positioning
(i.e., supine vs. semireclined positions
may generate different results for various
muscle groups)
d Criteria to be used to label a muscle as
“unassessable” (where unassessable may
refer to poor image quality or ability to
distinguish fascial borders for precise and
accurate quantiﬁcation)
The majority of reliability measures have
been focused on image analysis as opposed to
the fundamental data quality of image
acquisition. Validation and reliability work is
essential to conﬁrming that measurements are
consistent and speciﬁc to permit comparisons
across different studies.
Muscle Site
Heterogeneity exists in parameters measured
and reported, and this is probably the most
signiﬁcant barrier to external validity.
Standardization of speciﬁc muscles and
muscle groups to be analyzed is lacking.
Muscle mass changes have been focused on
both composite and individual muscles: rectus
femoris (either as cross-sectional area or
thickness; Figure 2) (17) or vastus lateralis
(thickness) (13) or muscle limb thickness
composed of rectus femoris and vastus
intermedius (Figure 2) (21) or individual
muscle groups (13). More recently, Fischer
and colleagues reported data using multiple
images and multiple sites (66). The best
image acquisition site also remains unknown,
with midthigh, 2/3, and 3/5 of femur length
all being used for the quadriceps.
The number of images needed for
adequate analysis of biomechanical
measures and metabolic integrity also
remains unstandardized. These diverse
measures could lead to a more targeted
approach not only to identifying patients at
risk of poor outcomes but also to
understanding underlying mechanisms in
muscle atrophy in this patient population.
Recent work has begun to address this,
demonstrating that muscle layer thickness
may underestimate muscle loss and cross-
sectional area may relate to strength to a
greater degree (69).
Image Acquisition and Analysis
There is variability in the data collected
across studies, which may include some or
all of the following: muscle layer thickness,
cross-sectional area, echogenicity, or a
combination of these and other
measurements. Within each of these
Table 1. Summary of limitations and challenges in using ultrasound for assessing
muscle health
Challenge or Limitation Description of Challenge or Limitation
Identiﬁcation of landmarks d Appropriate training is needed for consistent identiﬁcation
of landmarks.
d Standardized protocols on how to identify anatomical
landmarks for measurement are lacking.
d Reporting standards (in publications) are lacking for
landmarking.
d Reliability testing for landmarking is either lacking or
included within the entire data acquisition process (i.e.,
probe placement, image analysis).
Reliability testing d Reporting on reliability testing is often lacking.
d Standardization on how a reliability test is performed and
what is included in the testing procedure is lacking.
d Intra- and interreliability tests are either both lacking or only
one of the two tests is performed using ultrasound and
published in research studies.
Muscle site d Different muscles are often measured across different
studies (rectus femoris vs. vastus lateralis, upper limb vs.
lower limb, or a combination).
d Different methods are used for muscle quantity assessment
(i.e., cross-sectional area vs. muscle layer thickness).
d Best site to capture muscle groups consistently are unclear
(i.e. mid-thigh versus 2/3 femur length versus 3/5 femur
length)
Image acquisition
and analysis
d Form of analysis varies across studies (i.e., muscle layer
thickness, cross-sectional area, echogenicity). Some
studies use a combination of these methods.
d Different body composition phenotypes present distinct
challenges (e.g., obese individuals may have
indistinguishable fascial boundaries, fatty inﬁltration may
affect muscle thickness).
d Fluid status may affect measurements: use of minimal
versus maximal compression.
Equipment use d Appropriate use and reporting of curvilinear versus linear
probes
d Identiﬁcation of a minimal level of resolution for
echogenicity
d Software choice for image analysis varies
Normative data and
interpretation of results
d Limited studies that provide a healthy, homogeneous
cohort for comparison
d Measurement reporting is essential for longitudinal
evaluation but is currently missing in the literature.
d Identiﬁcation of the smallest detectable change for clinically
meaningful longitudinal analysis is needed.
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ultrasound measurements, patients in the
ICU have diverse body composition
phenotypes that present distinct challenges in
quantifying muscle. Obese patients typically
require greater scanning depth, with
subsequent loss of resolution. Fatty
inﬁltration within the muscle will confound
muscle thickness measures unless echogenic
factors are concurrently considered.
Echogenic factors, which are variables that
inﬂuence the “bounce back” or reﬂection of
ultrasound waves, differ across diverse
ultrasound devices. This heterogeneity in
echogenic factors may be challenging and
may limit the ability to compare results
without a phantom standard (a standard
tool that is used for calibration of multiple
pieces of equipment). Fluid status may also
affect echogenic factors, but there are
conﬂicting reports in this area of work
(59, 63). To overcome the issue of ﬂuid status,
some researchers have used full compression
of the probe in an attempt to remove the
confounding effect of edema (21, 28).
However, full compression may alter the size
and shape of muscle variably. Other
researchers have used minimal or no
compression whereby an excess of ultrasound
gel is used to minimize the distortion of the
image that typically results from skin
indentations caused by pressure of the
ultrasound probe (13, 59). Still others have not
reported their approach. Consequently, these
distinct techniques make it difﬁcult to
compare results across studies.
Image acquisition is also confounding
where interfaces of the muscle boundaries
can be challenging and add to error in
reliability and accuracy in aged and/or
morbid individuals. Cannulae from
external devices may also limit the available
scanning site (e.g., extracorporeal membrane
oxygenation cannulae overlying the
quadriceps) and prohibit image acquisition.
Clarity is also needed in determining the use
of bilateral versus unilateral limb
measurements as well as the number of
measures to be performed (and whether the
average or peak measure is reported).
Equipment Use
Linear arrays offer a range of resolutions
determined by transducer frequency.
Though direct comparisons have been
made between curvilinear and linear probes
(Figures 2D and 2E) (65), an as yet
unestablished minimum level of resolution
is required for echogenicity analysis of
muscle quality and detection of necrosis.
Multiple software platforms capable of
image analysis are used, but the impact of
subtle analytical differences (e.g., in
pixelation analysis) or equipment mode
selections (e.g., gain, depth) may also
preclude direct comparison of datasets.
Normative Data and Interpretation
of Results
There are a limited number of studies that
provide a healthy, homogeneous cohort for
comparison. As a consequence, there is
an essential need for normative data to
identify patients with low muscle mass.
Case–control studies are methodologically
difﬁcult, given the interindividual
variability in muscle size. Measurement
reporting needs to be considered, especially
in the context of longitudinal evaluation.
Percentage changes may be more
meaningful, but these percentages may
be misleading in the context of small
muscle groups or atrophied muscles.
For example, a loss of cross-sectional
area of 5 cm2 in a muscle group that was
40 cm2 at baseline equates to a 13% loss,
compared with a muscle that was 80 cm2 at
baseline, which equates to a 7% loss. Clear
distinctions need to be made between
statistically signiﬁcant differences and
clinically relevant changes while respecting
the intrinsic accuracy and variability of the
technique (66). Determining the smallest
detectable change that is permitted with
skeletal muscle ultrasound and assessing
the validity of this value is fundamental to
distinguishing true change from artifact.
Overall, investigators need to be clear with
regard to the quality, accuracy, and
reproducibility of data collected.
Table 2. General ultrasound protocol and reporting characteristics important to
include in publications
Reporting Characteristics Description of Information
Data acquisition
Identiﬁcation of landmarks d Diverse papers use various
landmarks.
d Choose the appropriate landmarks
for your study and refer to the paper
(s) that have used or validated these
landmarks.
Number of repeated measures d Identify the number of times that the
measurements (thickness or cross-
sectional area) were performed.
d Identify whether the largest,
smallest, or average of the repeated
measures was reported.
Identiﬁcation of “unassessable muscle” d Outline of the criteria used to
determine whether the quality of the
image would provide an unreliable
measure: “unassessable muscle”
d Example criteria may include inability
to distinguish fascial borders
between muscle and fat.
Reliability testing
Reliability tests for landmarking d Description of how the landmark
was tested for reliability
Reliability tests for measuring thickness
or cross-sectional area (CSA)
d Description of thickness or CSA
reliability tests performed
Blinding for reliability tests d Description of how the analyst was
blinded to “relandmarking” the area
of interest (e.g., if a mark had been
made on a given limb, was that mark
removed?)
d Describe how the analyst was
blinded to the reliability test for using
the measuring tools (e.g., screen/
electronic calipers).
Intra- versus interreliability d Identify the number of repeated tests
that were performed for reliability.
d Identify the coefﬁcient of variation for
the inter- and intrareliability tests.
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Perspectives: Optimizing Use
and Interpretations of Muscle
Ultrasound in the ICU
Muscle quantiﬁcation at ICU admission
and changes over time are potential
surrogate outcome measures for muscle
function as well as overall muscle health.
Muscle function and strength require
voluntary participation of the patient,
and these measurements are often precluded
by barriers such as sedation and delirium.
Nonvolitional measurements are
attractive in their ability to set a baseline
measurement at the onset of critical
illness. This relationship between muscle
mass and function should be examined
more thoroughly in the critically ill to
guide method development using
ultrasonography. The most optimal
method of understanding muscle health in
the ICU will likely require a combination of
several assessments, including systemic,
nutritional, functional, clinical, and
metabolic biomarkers, as well as muscle
quantity (e.g., thickness, cross-sectional
area, mass) and quality (including echogenic
factors). Algorithms for the most
predictive approaches should be
considered in future studies, but a ﬁrst
step is identifying a universal protocol
for characterizing muscle quantity and
quality.
Mitigating the degree of muscle wasting
during acute critical illness and regaining
muscle mass via rehabilitation are core targets
for improving patient outcomes in critical
care, and they are strongly associated (13).
Accurate and precise quantiﬁcation of
muscle mass is one step toward identifying
patients who have low muscle mass at ICU
admission. In combination with other
measures, future work in muscle
quantiﬁcation may help to identify those
who would beneﬁt most from targeted
nutrition and rehabilitative therapy.
Intervention evaluation aimed at preventing
or reducing muscle loss requires an accurate
and precise set of tools. Ultrasound has
several merits in providing a noninvasive,
nonvolitional, and accessible approach to
measuring quantity and quality of muscle.
Although ultrasound represents a potential
option for measurement of muscle mass in
real time in clinical facilities, ﬁrst a universal
protocol needs to be identiﬁed and validated
that can be easily implemented in the
critical care setting to enhance and advance
studies whose aim is to improve muscle
rehabilitation in survivors of critical illness.n
Author disclosures are available with the text
of this article at www.atsjournals.org.
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